Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Journal of Hepatocellular Carcinoma|September 22, 2025
A Multicenter Retrospective Study: Impact of First-Line Treatment Strategies on second-Line Efficacy and Safety of Regorafenib with or Without PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaWeihong Ma, Yinyin Li, Yinying Lu, et al.
Briefings in Bioinformatics|July 8, 2022
Evaluating methylation of human ribosomal DNA at each CpG site reveals its utility for cancer detection using cell-free DNAXianglin Zhang, Xiaodong Jia, Bixi Zhong, et al.
Cell Death & Disease|October 16, 2019
MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agentsBin Yang, Chunping Wang, Hui Xie, et al.
Journal of Hepatocellular Carcinoma|March 9, 2023
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular CarcinomaJin Lei, Sibo Yang, Bowen Chen, et al.
Hepatology International|December 29, 2022
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitorsJin Lei, Tao Yan, Linzhi Zhang, et al.
Drug Design, Development and Therapy|January 4, 2023
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World StudyBowen Chen, Linzhi Zhang, Jiamin Cheng, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 26, 2024
NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironmentLiangzheng Chang, Lei Xu, Yuying Tian, et al.
Journal of Hepatocellular Carcinoma|November 17, 2022
Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective StudyBowen Chen, Jin Lei, Haitao Zhao, et al.
Clinical & Experimental Metastasis|September 29, 2009
Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective studyChunping Wang, Yinying Lu, Yan Chen, et al.
Oncology Research|April 1, 2024
Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinomaXinfeng Zhang, Shuang Li, Meiru Song, et al.
Pageof 12